Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × sargramostim × Clear all

NCT02703714 2022-01-25

Pembrolizumab and GM-CSF in Biliary Cancer

Phase 2 Completed

42 enrolled 19 charts

Gastrointestinal

Biliary Tract Neoplasms